Newsletter Subject

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Aug 30, 2024 08:05 PM

Email Preheader Text

Oncology Update Friday, August 30, 2024 ADVERTISEMENT Exclusives & Features PURPOSE: Durable partial

[MEDPAGE TODAY]( Oncology Update Friday, August 30, 2024 [Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza']( [Benefits of Neoadjuvant Immunotherapy in Breast Cancer Extend Beyond TNBC]( [Lung Function Stable in Sickle Cell Patients After Non-Myeloablative Transplant]( [Is Exercise an Effective Treatment for Prostate Cancer?]( [Lasting Reductions in CRC Incidence, Death With Single Sigmoidoscopy]( [PERSPECTIVES]( [Your Patient Has Been Dealt a Hand With Four ACEs. What Now?]( ADVERTISEMENT Exclusives & Features [Hospitals Hire Chief AI Officers; Biased AI Images of Docs; Journal Wants AI Methods]( [Neurologists Are the Latest Specialists to Exit Mission Health]( [Liveyon CEO Convicted in Stem Cell Scheme That Sickened Many]( [Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.]( PURPOSE: Durable partial response (PR) and durable stable disease (SD) are often seen in patients with hepatocellular carcinoma (HCC) receiving atezolizumab plus bevacizumab (atezo-bev). This study... [READ MORE]( [Blood immunomap for prediction of responses to aPD1 immunotherapy in metastatic non-small cell lung cancer]( Immune checkpoint inhibitor immunotherapy has revolutionized the treatment of non-small cell lung cancer (NSCLC). Despite the immense success, still a significant proportion of patients do not... [READ MORE]( [Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.]( Outcomes are poor in triple-class-exposed (TCE) relapsed/refractory multiple myeloma (RRMM). In the phase 3 KarMMa-3 (clinicaltrials.gov; NCT03651128) trial, patients with TCE RRMM and 2-4 prior... [READ MORE]( [Gerotherapeutics: Aging Mechanism-based Pharmaceutical and Behavioral Interventions to Reduce Cancer Racial and Ethnic Disparities.]( The central premise of this article is that a portion of the established relationships between social determinants of health and racial/ethnic disparities in cancer morbidity and mortality are... [READ MORE]( [From Battling Breast Cancer to Inspiring Hope: Gracita Eugene’s Remarkable Journey of Courage and Compassion - Daily Nurse]( Gracita Eugene, a dedicated chemotherapy nurse with Memorial Hermann Health System in Houston, Texas, recently emerged victorious from her battle with breast cancer. What makes her journey... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-08-30&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.